Indometacin/L-menthol

吲哚美辛/L-薄荷醇

Report date: 2024/01/06 20:00:48

Base Information

Drug NameIndometacin/L-menthol

Drug Alias NameIndometacin+LevomentholK-285

ClassificationSmall molecules

Mechanisms of ActionKappa opioid receptor antagonistsTransient receptor potential cation channel subfamily M member 8 agonistsTransient receptor potential cation channel subfamily A member 1 inhibitors +[4]

TargetsCyclooxygenasesTransient receptor potential cation channel subfamily A member 1Kappa opioid receptor +[4]

Therapy Area/IndicationsAcute Pain

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsYes Levomenthol Indomethacin

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesKowa Dental Health Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKowa Research Institute Inc

Active IndicationsN/A

Inactive IndicationsAcute Pain

Other Information

ATC CodeN/A